Alfin Vicencio, MD Email Alfin Vicencio
- PROFESSOR | Pediatrics
- Pediatric Pulmonology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Queens
- Mount Sinai Beth Israel
Dr. Alfin G. Vicencio is the Chief of the Division of Pediatric Pulmonology and Vice Chair for Clinical Affairs and Strategy for the Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children's Hospital. After completing his undergraduate studies at the University of Notre Dame and obtaining his medical degree from the University of Toledo, he relocated to the East Coast, where he completed a pediatric residency at Babies and Children's Hospital (Columbia University) and a pediatric pulmonology fellowship at Yale University. A primary clinical interest of his over the past several years has been severe and refractory asthma. Together with several regional collaborators, Dr. Vicencio is investigating the potential role of microbial organisms (including fungi) in severe asthma, as well as formulating new diagnostic and treatment plans for such patients. In addition to his work in asthma, he has extensive experience in diagnostic and interventional flexible bronchoscopy in children. Dr. Vicencio has published on a variety of topics including asthma, flexible bronchoscopy, wheezing, tracheobronchomalacia, bronchiolitis and bronchopulmonary dysplasia, and has been recognized as a "Top Doctor" both regionally and nationally.
Read "Novel Findings: Nasal Gene Expressions of ACE2 in Children and Adult" in the Mount Sinai Kravis Children's Hospital's 2021 Pediatric Report.
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Bronchogenic Cyst
- Bronchopulmonary Dysplasia
- Bronchoscopy, Diagnostic
- Cystic Fibrosis
MD, Medical College of Ohio Hospital
New York Presbyterian / Columbia University
Yale New Haven Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Vicencio did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.